Lanxess (LXS) Given a €67.00 Price Target at Goldman Sachs Group
A number of other equities analysts also recently weighed in on the company. Credit Suisse Group set a €70.00 ($81.40) price target on Lanxess and gave the stock a neutral rating in a research report on Wednesday, October 3rd. UBS Group set a €53.00 ($61.63) price target on Lanxess and gave the stock a neutral rating in a research report on Monday. JPMorgan Chase & Co. set a €55.00 ($63.95) price target on Lanxess and gave the stock a buy rating in a research report on Thursday. Deutsche Bank set a €68.00 ($79.07) price target on Lanxess and gave the stock a neutral rating in a research report on Friday, September 21st. Finally, Kepler Capital Markets set a €86.00 ($100.00) price target on Lanxess and gave the stock a buy rating in a research report on Tuesday, September 25th. Four investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and ten have given a buy rating to the company’s stock. Lanxess presently has a consensus rating of Hold and an average target price of €64.25 ($74.71).
LXS traded down €0.69 ($0.80) on Thursday, hitting €45.69 ($53.13). 458,744 shares of the company were exchanged, compared to its average volume of 312,027. Lanxess has a 12 month low of €59.89 ($69.64) and a 12 month high of €74.50 ($86.63).
LANXESS Aktiengesellschaft, a specialty chemicals company, develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. It operates in five segments: Advanced Intermediates, Specialty Additives, Performance Chemicals, Engineering Materials, and ARLANXEO. The Advanced Intermediates segment offers high-grade intermediates for the agrochemical and coating industries; fine chemicals as precursors and intermediates for the pharmaceutical, agrochemical, and specialty chemical industries; customer-specific specialties; organometallics; and tire chemicals.
Read More: Reverse Stock Split
Receive News & Ratings for Lanxess Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lanxess and related companies with MarketBeat.com's FREE daily email newsletter.